Capricor Therapeutics (NASDAQ:CAPR) focuses on developing cell and exosome-based therapies for genetic disorders like Duchenne muscular dystrophy.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Capricor Therapeutics (NASDAQ:CAPR) focuses on developing cell and exosome-based therapies for genetic disorders like Duchenne muscular dystrophy.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing